Arkolith/Insider Trading/MAZE/Form 4

Coloma Jason V

Chief Executive Officer, DirectorMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Jun 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$174K
Net Open-Market Flow
-$174K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Sell(S)6K$26.20$160K345K
Jun 1, 2026Sell(S)553$26.24$15K28K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001676170-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML